The number that arrives without a receipt
When a pharmacy hands you a price for a prescription, it tends to land like a fact of nature. There is no itemized breakdown, no "here is what it cost us and here is our margin." There is just a number, and the quiet expectation that you will either pay it or walk away. Most of us pay. We are usually unwell, often in a hurry, and almost never holding a second price to compare it against.
But that number is not weather. It is built. And one of the closest things we have to a public blueprint of how it gets built is an awkward government acronym most people have never heard of: NADAC.
What NADAC actually measures
NADAC stands for the National Average Drug Acquisition Cost. It is published by the Centers for Medicare & Medicaid Services — the federal agency, usually shortened to CMS, that runs Medicare and Medicaid — and it answers one narrow, useful question: on average, across the country, what does a retail pharmacy actually pay to buy a given drug?
That word acquisition is the whole point. NADAC is not a retail price, not an insurance price, and not a suggested price. It is the wholesale cost — what the pharmacy paid the distributor for the bottle before a single pill reaches you. CMS builds the figure from a voluntary monthly survey of retail community pharmacies, collecting their real invoice costs and averaging them into a per-unit number: per tablet, per milliliter, per gram. The list is refreshed every week as new survey data comes in.
So NADAC is, in effect, the floor of the conversation. It is roughly what your medication cost the store. Everything you pay on top of that — rent, staff, the pharmacist's time, profit — is the markup. NADAC doesn't tell you what that markup should be. It just makes the markup visible, which is something the pharmacy counter is not designed to do.
Why a wholesale number is so useful to a patient
Here is the strange gap NADAC exposes. For a common generic, the acquisition cost is often startlingly low — pennies per pill for some long-established medications. Yet the cash price two patients pay for that identical drug, in the same city, on the same afternoon, can differ by a multiple of five or ten. The drug didn't change. The acquisition cost barely moved. What changed was the markup, and the markup is the part nobody narrates to you.
Knowing the rough acquisition cost reframes the entire transaction. A price isn't simply "expensive" or "cheap" in the abstract — it is expensive or cheap relative to what the pharmacy paid. A medication that cost the store very little but is being sold to you for a great deal more isn't a bargain just because it's a generic. And a price that sits only modestly above the acquisition cost is, by any reasonable standard, a fair one — even if it still feels like a lot.
This is also why the same pill can swing in price month to month. Generic acquisition costs genuinely fluctuate as manufacturing supply tightens or loosens, and NADAC's weekly updates track those real movements. But a sudden jump in your price, when the underlying acquisition cost has held steady, is a markup story, not a supply story. Without a benchmark, you can't tell the two apart. With one, you can.
The quiet psychology of the counter
There is a behavioral reason we accept that first number so readily, and it has a name: anchoring. Decades of research on judgment under uncertainty show that the first figure we encounter becomes the reference point against which we judge everything after it — even when that first figure is arbitrary. At the pharmacy, the price the register shows is the anchor. With nothing to compare it to, your mind treats it as the center of the reasonable range, and any discount card or coupon feels like a win simply because it pulls you below an anchor you never had reason to trust.
A second force is at work too. Behavioral economists describe the discomfort of parting with money as the pain of paying — and that pain is sharpest in exactly the moments we're least able to think clearly. You are at the counter because something is wrong: you're sick, or your child is, or you're managing a condition that already takes up too much mental space. Economists call the resulting depletion decision fatigue, and it makes the path of least resistance — pay and leave — almost irresistible. The pharmacy isn't manipulating you. The situation simply isn't built for comparison shopping, and your tired brain knows it.
The antidote to both forces is the same: bring your own anchor. If you walk in already knowing the national-average neighborhood a fair price lives in, the register's number stops being the center of gravity. It becomes one data point you can evaluate, accept, or quietly decline — and the decision moves back to you.
How to use the benchmark in real life
NADAC is public data, and you can use the idea behind it without becoming a pricing analyst. A few practical moves:
Look up the typical number before you fill, not after. The benchmark is only an anchor if it arrives first. Once you've paid, anchoring works against you — the price you paid becomes the reference for next time.
Compare your quoted price to the acquisition-cost neighborhood, not to your fears. The useful question isn't "is this a lot of money?" It's "how far above what the pharmacy paid is this?" A small gap is the cost of running a pharmacy. A large one is a reason to make a phone call.
Call two or three pharmacies before you transfer or fill. Because the markup — not the drug — is what varies, the same prescription genuinely costs different amounts at different counters. Independent pharmacies and warehouse-club counters often price generics close to acquisition cost; some chains mark them up steeply. You can't know which is which without asking, and asking takes minutes.
Treat discount cards as a comparison, not a verdict. A coupon that beats the register price still might not beat a fair cash price elsewhere. The benchmark tells you whether the "discount" is actually a discount.
What a fair price really means
None of this is an argument that pharmacies shouldn't profit. They are businesses, and dispensing a medication safely is skilled work that deserves to be paid for. The argument is narrower and gentler: you deserve to know roughly where the floor is, so that the markup is a thing you can see and weigh rather than a thing that simply happens to you.
That is the whole gift of a benchmark like NADAC. It doesn't accuse anyone. It just turns a closed transaction into an open one — replacing "this is the price" with "this is the price, and here is the neighborhood a fair one lives in." In that small shift, an uneven exchange becomes something closer to an informed choice.
Carrying the benchmark in your pocket
This is exactly the gap SnapRx was built to close. Snap a photo of your prescription label and it shows you the fair, national-average cash price drawn from the same CMS NADAC data described here — your anchor, ready before you reach the counter — then helps you find real pharmacies nearby to call and confirm. You walk in knowing the typical number instead of discovering it at the register.
If you'd like to see the fair price for a medication you take before your next refill, you can try it at snaprx.lumenlabs.works. Even if you never fill a prescription any differently, knowing where the floor sits is worth the thirty seconds it takes to look.